FDA Drug Application (125104) for TYSABRI by BIOGEN IDEC

Back to FDA Applications sponsored by BIOGEN IDEC

Application Number125104
Product Number001
FormVIAL; SINGLE-USE
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTYSABRI
Active IngredientNATALIZUMAB



Back to FDA Applications sponsored by BIOGEN IDEC